← All trials
NCT04655976
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 8, 2020
- Primary completion
- Sep 6, 2024
- Completion date
- Jan 1, 2026
- First posted
- Dec 7, 2020
- Last posted
- Nov 17, 2021
- Enrollment
- 250
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- GlaxoSmithKlineLead sponsor
- GlaxoSmithKlineStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.